公开(公告)号：US20210053952A1

公开(公告)日：2021-02-25

申请号：US16959339

申请日：2019-01-10

Applicant: UCB Biopharma SRL

Inventor： Gareth Neil Brace ,  Rose Elizabeth Chappell ,  Gregory Foulkes ,  James Richard Frost ,  Helen Tracey Horsley ,  Elizabeth Pearl Jones ,  Fabien Claude Lecomte ,  James Thomas Reuberson ,  Monika-Sarah Elizabeth Dorothea Schulze ,  Richard David Taylor ,  Wei Tsung Yau ,  Zhaoning Zhu

IPC: C07D407/14 ,  C07D413/12 ,  C07D413/14 ,  C07D235/16 ,  C07D401/14

Abstract: A series of substituted fused bicyclic imidazole derivatives, including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.

公开(公告)号：US11472794B2

公开(公告)日：2022-10-18

申请号：US16959339

申请日：2019-01-10

Applicant: UCB Biopharma SRL

Inventor： Gareth Neil Brace ,  Rose Elizabeth Bardell-Cox ,  Gregory Foulkes ,  James Richard Frost ,  Helen Tracey Horsley ,  Elizabeth Pearl Jones ,  Fabien Claude Lecomte ,  James Thomas Reuberson ,  Monika-Sarah Elizabeth Dorothea Schulze ,  Richard David Taylor ,  Wei Tsung Yau ,  Zhaoning Zhu

IPC: C07D403/12 ,  C07D413/12 ,  C07D407/14 ,  C07D235/16 ,  C07D401/14 ,  C07D413/14

Abstract: A series of substituted fused bicyclic imidazole derivatives, including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.

公开(公告)号：US11052076B2

公开(公告)日：2021-07-06

申请号：US16619573

申请日：2018-06-12

Applicant: UCB BIOPHARMA SRL

Inventor： Gareth Neil Brace ,  Rose Elizabeth Chappell ,  Hervé Jean Claude Deboves ,  Anne Marie Foley ,  Gregory Foulkes ,  Elizabeth Pearl Jones ,  Fabien Claude Lecomte ,  Joanna Rachel Quincey ,  Monika-Sarah Elisabeth Dorothea Schulze ,  Matthew Duncan Selby ,  Adam Peter Smalley ,  Richard David Taylor ,  Robert James Townsend ,  Zhaoning Zhu

IPC: C07D471/10 ,  C07D487/10 ,  C07D495/10 ,  C07D491/20 ,  A61K31/4439 ,  A61K31/407 ,  A61K31/4155 ,  A61K31/4192 ,  A61K31/4196 ,  A61K31/422 ,  A61K31/427 ,  A61K31/433 ,  A61K31/437 ,  A61K31/501 ,  A61K31/502 ,  A61K31/506 ,  C07D491/107 ,  C07D519/00

Abstract: A series of substituted spirocyclic 2-oxoindoline derivatives, and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.